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Mitochondrial diseases are a group of rare life-threatening diseases often caused by
defects in the oxidative phosphorylation system. No effective treatment is available
for these disorders. Therapeutic development is hampered by the high heterogeneity
in genetic, biochemical, and clinical spectra of mitochondrial diseases and by limited
preclinical resources to screen and identify effective treatment candidates. Alternative
models of the pathology are essential to better understand mitochondrial diseases and
to accelerate the development of new therapeutics. The fruit fly Drosophila melanogaster
is a cost- and time-efficient model that can recapitulate a wide range of phenotypes
observed in patients suffering from mitochondrial disorders. We targeted three important
subunits of complex I of the mitochondrial oxidative phosphorylation system with the
flexible UAS-Gal4 system and RNA interference (RNAi): NDUFS4 (ND-18), NDUFS7
(ND-20), and NDUFV1 (ND-51). Using two ubiquitous driver lines at two temperatures,
we established a collection of phenotypes relevant to complex I deficiencies. Our data
offer models and phenotypes with different levels of severity that can be used for
future therapeutic screenings. These include qualitative phenotypes that are amenable
to high-throughput drug screening and quantitative phenotypes that require more
resources but are likely to have increased potential and sensitivity to show modulation
by drug treatment.
Keywords: mitochondrial disease, complex I deficiency, Drosophila melanogaster, disease model, screening
INTRODUCTION
With one out of 5000 live births affected (Skladal et al., 2003; Schaefer et al., 2004), mitochondrial
diseases are classified as rare diseases. They often are caused by defects of the oxidative
phosphorylation (OxPhos) system (Smeitink et al., 2001). Mitochondrial diseases with early onset
presentation show a broad phenotypic spectrum and are associated with poor prognosis and/or
premature death in the majority of cases. Currently, only supportive care can be offered to patients.
There is an urgent medical need for effective drugs to treat mitochondrial diseases to prevent
their severe progression. Because mitochondrial diseases form a family of highly heterogeneous
conditions (Distelmaier et al., 2009; Vafai and Mootha, 2012; Moggio et al., 2014), developing
various animal models to understand the pathomechanisms of the different mitochondrial diseases
and test treatment strategies is highly relevant (Foriel et al., 2015). The identification and the
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use of multiple models recapitulating a spectrum of symptoms
encountered in patients with mitochondrial diseases may be more
predictive and present a better strategy toward identification of
effective therapeutics.
A great advantage of Drosophila melanogaster as a model
organism, apart from its general features (Jennings, 2011; Pandey
and Nichols, 2011), is the flexibility of the utilized UAS-
Gal4 system to control the knockdown (KD) of specific genes
(Brand and Perrimon, 1993). The yeast transcription factor Gal4
determines the spatial and temporal expression of a transgene
located downstream of an Upstream Activating Sequence (UAS).
The temperature sensitivity of this binary system (Duffy, 2002)
allows to fine-tune the severity of the induced KD and therefore
to adjust and select suitable conditions. We developed an array
of KD models and phenotypes recapitulating several features
of mitochondrial complex I deficiency as the most frequently
mutated OxPhos complex (Loeffen et al., 2000; Smeitink et al.,
2001; Fassone and Rahman, 2012). Among the 44 subunits
forming the human CI, 42 are evolutionary conserved in
Drosophila, highlighting the important role of each of these
building blocks (Garcia et al., 2017). In this study, we used RNA
interference (RNAi) to target the expression of three subunits
known to play crucial roles in CI function and to be prone to
mutations in patients (Zeviani et al., 2003; Koene et al., 2012; Lake
et al., 2015; Mayr et al., 2015; Koopman et al., 2016). NDUFV1
(V1) and NDUFS7 (S7) are two core subunits that play crucial
roles in the catalytic function of the complex: V1 is involved in the
oxidation of NADH into NAD+, creating the flow of electrons. S7
is required for the transfer of electrons to ubiquinone. NDUFS4
(S4) on the other hand is an accessory subunit which appears to
be important for the structural integrity of the complex (Janssen
et al., 2006; Mimaki et al., 2012; Valsecchi et al., 2012; Varghese
et al., 2015). Mutations in these subunits lead to very severe
early onset symptoms and poor prognosis for the patients. For
each subunit, we used two ubiquitously expressed Gal4 lines to
induce the KD [actin-Gal4 and daughterless (da)-Gal4] and two
temperatures (25 and 28◦C) to generate a panel of phenotypes.
We then based our screening on four parameters: the percentage
of residual gene expression, the OxPhos complexes activity, the
eclosion rate, and survival analysis. Here we report robust and
disease-relevant phenotypes that could be suitable for future
modification by pharmacologic treatment.
MATERIALS AND METHODS
Utilized Stocks and Fly Husbandry
The KD of mitochondrial CI subunits was induced using the
binary UAS-Gal4 system (Brand and Perrimon, 1993). The
utilized RNAi lines were vdrc101489 to target ND-18 (the
NDUFS4 Drosophila ortholog), vdrc110881 to target ND-20 (the
NDUFS7 Drosophila ortholog), vdrc43184 to target ND-51 (the
NDUFV1 Drosophila ortholog) and their genetic background
vdrc60000 (control GD for NDUFV1) and vdrc60100 (control
KK for NDUFS4 and NDUFS7) from Vienna Drosophila
Resource Center (VDRC). In terms of sequence-related off-
targets, these lines fulfill the highest standard: vdrc101489
(CG12203; NDUFS4) s19 = 1; off targets = 0; vdrc101881
(CG9172; NDUFS7) s19 = 1; off targets = 1, corresponding to
CG2014, the second S7 paralog in Drosophila that is specifically
expressed only in testis; vdrc43184 (CG9140; NDUFV1) s19 = 1;
off targets = 0. In addition, both vdrc101489 and vdrc110881,
the two utilized RNAi lines from the vdrc KK library underwent
diagnostic PCRs according to Green et al. (2014). These validated
the hairpin integrations at position 30B on chromosome 2L,
and excluded a hairpin integration at position 40D that can be
associated with dominant off-target phenotypes (Green et al.,
2014; Vissers et al., 2016). S4/actin/28◦C KD and phenotypes
have previously been published (Foriel et al., 2018) and were
reproduced/adapted with the permission from Disease Models
and Mechanisms (DMM). In Drosophila, NDUFS7 and NDUFV1
have several orthologs (S7: ND-20 and ND-20L; V1: ND-51, ND-
51L1, and ND-51L2). We chose to target ND-20 (S7) and ND-51
(V1), which are widely expressed. Since ND-20L (S7), ND-51L1
(V1), and ND-51L2 (V1) presented with high expression solely in
the testis and imaginal disc L3, they were not further considered
in this study. Throughout Drosophila development, four peaks
of expression were observed for ND-18, ND-20, and ND-51:
(1) a moderate to high expression during the early embryonic
stages from embryo 0–2 h to embryo 12–14 h), (2) a very
high expression period from late embryogenesis until larval L3
12 h, (3) a moderate to high expression during pupae post
white prepupae, and (4) a phase of high/very high expression
from mid-pupal stages until 30 days old adults (according to
Flybase modENCODE temporal expression data). The actin-
Gal4/TM6c, Sb Tb driver was obtained from Christiane Zweier
(Humangenetisches Institut, Germany) and w, P{da-Gal4, w+}
G32III was obtained from Pascal Heitzler (IGBMC, Strasbourg,
France). All stocks were maintained on standard cornmeal-agar
medium at 25◦C in a 12 h:12 h light dark cycle.
Ten females of the RNAi lines and their appropriate isogenic
control line were crossed with 10 males of either the actin-
or the da-Gal4 line at 25 or 28◦C and 60% humidity. After
24 h of premating, the crosses were transferred to a new vial,
referred to as experimental vial, for 2–3 days to raise an adequate
population density.
Eclosion Rate
Fifteen days after the transfer to the experimental vials, the
total number of pupae and empty pupae were counted manually
with a cell counter for each vial to evaluate the percentage
of eclosion. GraphPad Prism 6 (GraphPad software, La Jolla,
CA, United States) was used for statistical analysis with
Student’s t-test with Welch’s correction (when the variance
was different) to determine statistical significances (∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001). Of note, eclosed adult flies
of the S4/da/28◦C model, frequently fall into the food and
die soon after eclosion. As a consequence, the eclosion rate
is not necessarily representative of the number of living
adult flies. Despite similar eclosion rates between S4/da/28◦C
and S7/actin/25◦C, we could not obtain enough living adult
to carry the OxPhos activity measurements. Crosses with
daughterless driver and S7 presented with strong delay in
pupariation formation.
Frontiers in Genetics | www.frontiersin.org 2 March 2019 | Volume 10 | Article 245
fgene-10-00245 March 26, 2019 Time: 16:16 # 3
Foriel et al. Drosophila Mitochondrial Deficiency Phenotype Array
OxPhos Enzymatic Activity
One day old adult female KD flies were collected in groups
of 30 in triplicates and snap frozen (unless for S7/da/25◦C
n = 1). The 30 flies (whole bodies) were homogenized in 1 ml
SETH buffer (0.25 M sucrose, 2 mM EDTA-K, 10 mM Tris,
5 × 104 U/l heparine) with a glass pestle and centrifuged at
600 g for 10 min at 4◦C. The supernatant was divided in two
aliquots of 200 µl and used for OxPhos measurement (complexes
I, II, III, and IV). The rest of the supernatant was centrifuged
at 14,000 g for 10 min at 4◦C. The pellet was resolubilized in
400 µl of Tris HCl (pH 7,6) and used for complex V activity
measurement. The OxPhos enzyme activities were measured
by spectrophotometry with an automated Konelab 20XTi
instrument (ThermoFischer) at 37◦C. In brief, (1) the rotenone
sensitive CI activity was determined following the reduction of
2,6-dichlorophenolindophenol (DCIP) at 600 nm using NADH
and coenzyme Q1 as substrate; (2) CII activity was measured as
malonate sensitive DCIP reduction at 600 nm using succinate
and decylubiquinol as substrates; (3) CIII activity was determined
following the reduction of cytochrome c at 550 nm after addition
of decylubiquinol and cytochrome c; (4) CIV activity was
obtained following cytochrome c oxidation at 550 nm using
reduced cytochrome c as a substrate; and finally (5) oligomycin
sensitive CV activity was assessed following NADH oxidation
at 340 nm using ATP as substrate (see Table 1 in Rodenburg,
2011 for detailed information concentrations, substrates, assay
conditions, and readouts). The activity values obtained for each
complex were normalized against the citrate synthase (CS)
activity and presented as percent of averaged values of the control
flies. A multiple comparison test with Bonferroni correction was
performed using GraphPad Prism 6 to determine the statistical
significance of differences (∗p< 0.05; ∗∗p< 0.01; ∗∗∗p< 0.001).
Survival
Female KD flies were collected under CO2 on the day of eclosion
and placed in new vials with fresh food in groups of 20 individuals
at the appropriate temperature (25 or 28◦C) according to the
setting of the experiment. They were transferred to new vials
with fresh food every 2–3 days maximum to prevent them to die
due to bad food conditions (dry food, mold, or sticky food). The
number of dead flies was counted every day. Each experiment was
repeated at least two times (unless the eclosion rate did not allow
it). Kaplan Meier curves and statistical analysis were generated
using the GraphPad Prism 6 survival function, with a log-rank
Mantel–Cox test to determine statistical significances (∗p< 0.05;
∗∗p< 0.01; ∗∗∗p< 0.001; ∗∗∗∗p< 0.0001).
TABLE 1 | Sequences of primers used for qRT-PCR.
Name Sequence 5′ > 3′
dNDUFS4 forward AAGATCACCGTGCCGACTG
dNDUFS4 reverse GACAATGGGTCGCCGCTG
dNDUFS7 forward GAAGTGGCCCAAAATCTGCC
dNDUFS7 reverse GAGCAGATCGTCCAGTCTGG
dNDUFV1 forward TTGGTGGTGAATGCCGATGA
dNDUFV1 reverse ATGATCTCGCGATCCTTGCA
Quantitative Reverse Transcription –
Polymerase Chain Reaction (qRT-PCR)
Primers were designed with the Primer 3 Plus software1 using
the D. melanogaster dNDUFS4 (ND-18, CG12203), dNDUFS7
(ND-20, CG9172), and dNDUFV1 (ND-51, CG9140) nucleic acid
sequence from the Ensembl database2 (sequences in Table 1).
Prior to experiments, the primer pairs were tested for
efficiency (criterion: 0.95 < R2 < 1) and specificity (criterion:
single peak in the dissociation melting curve). To evaluate the
RNAi-induced KD efficiency, third instar larvae (n = 10 whole
larvae per sample) and one day old female adult flies (n = 5
whole fly bodies per sample) of the appropriate genotypes (CI
subunit crossed with either actin or daughterless driver) and
temperature (25 or 28◦C) were collected in triplicates and snap
frozen in liquid nitrogen. The total RNA from control and KD
larvae/adults was isolated following the RNeasy Lipid Tissue
Mini kit instructions from Qiagen. The RNA concentration
was measured with a nanodrop device (ThermoFischer). DNAse
treatment with the DNA-free kit (Ambion) was used to
remove genomic contamination prior to cDNA synthesis (Bio-
Rad iScriptTM Reverse Transcription Supermix). The qPCR
was performed using SyBR Green GoTaq R© qPCR Master Mix
(Promega). Relative gene expression was determined against
the geometric mean of two housekeeping genes: γ-tubulin
(forward: 5′-TAATGGGCTCGGTCTACTCC-3′ and reverse: 5′-
TGTCGAATACCTCTTCTTGCAG-3′) and RNA polymerase 2
(forward: 5′-CCGCGATACTTCTCTCCAC-3′ and reverse: 5′-
GACCAGCTAGGCGACATTC-3′). Three biological and two
technical replicates were performed for each genotype. Student
t-test was performed with Welch correction using GraphPad
Prism 6 to determine statistical significances (∗p < 0.05;
∗∗p< 0.01; ∗∗∗p< 0.001).
RESULTS
To develop models for mitochondrial CI deficiencies, we crossed
the transgenic RNAi lines to driver lines actin-Gal4/TM6c Sb
Tb and da-Gal4, respectively, to induce ubiquitous KD of the
CI subunits NDUFS4, NDUFS7, and NDUFV1 (from here on
referred to as S4, S7, and V1) at two different temperatures, 25
and 28◦C. qRT-PCR analysis at larval and adult stages validated
these models and revealed the degree of gene KD in comparison
to their appropriate isogenic controls for each subunit of interest
in all the tested conditions (three RNAi lines × two driver
lines × two temperatures). Overall, all the models presented
with a stronger KD at 28◦C except for S7/actin and S7/da
(Supplementary Figures S1, S2 and Supplementary Table S1).
Limited sensitivity of the q-PCR or experimental variation may
underlie this exception; no differences were observed between
relative S7 expression in the S7/da/25◦C and S7/da/28◦C KD
models (P = 0.076), or between their controls (P = 0.859). This
indicates that the temperature range (25–28◦C) does not have
effect on S7 transcript levels.
1http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/
2http://www.ensembl.org/index.html
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In patients, mutations in subunits of complex I can cause
isolated or combined OxPhos enzymatic activity disturbances.
To determine whether knocking down of Drosophila CI subunits
leads to comparable defects, we measured the activity of the five
OxPhos complexes in the adult KD models and compared these
to the complex activities of their isogenic controls and to previous
data obtained for the S4 subunit (Foriel et al., 2018). Without
any exception, all models that were sufficiently viable to allow
collection of adult progenies presented a strong reduction of
CI activity. CI activity levels ranged between 15.5 (S4/da/25◦C)
and 39.3% (S7/da/25◦C) of residual activity. In addition, some
models showed differences in the activity of other complexes.
CIII activity was upregulated in several models, with levels up
to 370.4% in the S4/da/25◦C model, relative to control levels.
S4/actin/25◦C was the only model to present a significantly lower
CV activity (60.3%), while S7 KD flies instead had an increased
CIV activity with both actin and da at 25◦C (144.9 and 150.5%)
and an increase of CII activity only for S7/actin/25◦C (144.8%).
The low number of adult escapers available for S7/actin/25◦C
prevented the generation of replicates and statistical analysis
for this specific condition. However, the same tendencies of
reduced CI activity and increased CIII activity were observed
(Figure 1 and Supplementary Table S1). These data confirm
that ubiquitous KD of CI subunits induces CI deficiency in
Drosophila, in some cases with consequences on the enzymatic
activity of other OxPhos complexes.
Having confirmed the CI deficiencies in the panel of
generated models, we set out to identify quantitative and
disease-relevant phenotypes that can be used as a readout for
drug testing. Metamorphosis is a crucial step of Drosophila
development during which the insects rely solely on the energy
reserves acquired during larval development. If the amount
of energy stores accumulated is rather low, the animals enter
the metamorphosis on a “metabolic edge” which can impact
directly on the survival success of the young adult (Merkey
et al., 2011). Since defective mitochondria might lead to energy
storage defects, we evaluated the percentage of eclosed flies by
counting the empty and total number of pupae. Based on our
previous work characterizing the S4/actin/28◦C model (Foriel
et al., 2018), we asked whether eclosion is also affected in S7,
V1, and other S4 models. Our collection of CI-deficient models
showed a wide range of eclosion rates, which can be classified
in four groups (Figure 2): (1) no eclosion impairment such
as S4/da/25◦C with 93.7% of the flies eclosing compared to
97.1% for its control KK/da/25◦C, (2) a modest impairment with
S4/actin/25◦C and S4/actin/28◦C with, respectively, 68.9 and
36.9% of eclosed pupae in comparison to their respective control:
control KK/actin/25◦C (95.0%) and control KK/actin/28◦C
FIGURE 1 | Enzymatic characterization of OxPhos activities in CI KD flies. Enzymatic measurement of the activity of mitochondrial OxPhos complexes, normalized
on citrate synthase (CS) activity and presented as a percentage of their respective controls (mean ± SEM, two-way ANOVA, statistical significances: ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001). CI activity was significantly reduced in all models. Other complexes activities were either significantly increased (CII in S7/Actin/25◦C, CIII
in all models, CIV in S7/Actin/25◦C and S7/da/25◦C) or significantly decreased (CV in S4/Actin/25◦C). The numerical values are provided in Supplementary
Table S1 (S4/actin/28◦C graph reproduced/adapted with permission from Foriel et al., 2018).
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FIGURE 2 | Consequences of CI subunits knockdown for eclosion. Percentage of eclosed pupae from the total number of pupae (mean ± SEM, unpaired Student’s
t-test, statistical significances: ns, non-significant; ∗∗∗P < 0.001). Except for S4/da/25◦C, all models displayed a reduced eclosion rate as compared to their
controls, ranging from 1.6 ± 0.6% in S7/actin/28◦C to 68.9 ± 2.2% reduction in S4/actin/25◦C. The eclosion rates numerical values are provided in
Supplementary Table S1 (S4/actin/28◦C graph reproduced/adapted with permission from Foriel et al., 2018).
(95%), (3) a severe impairment with S4/da/28◦C, S7/actin/25◦C,
S7/da/25◦C for which eclosion rates were 16.3, 19.1, and
11.5%, respectively [significant for all of them in comparison to
their respective controls: control KK/da/28◦C (97.5%), control
KK/actin/25◦C (95%), and control KK/da/25◦C (97.1%)], and
(4) very severe eclosion defects with S7/actin/28◦C, S7/da/28◦C,
V1/actin-da/25–28◦C, having eclosion rates below 2% and
lethality at larval (L1, L2, and L3) and pupal stages. Independently
from the subunit targeted, the driver used, or the temperature
applied, each model, except S4/da/25◦C, showed eclosion defects
highlighting a high mortality rate at metamorphosis or pharate
stages (Figure 2 and Supplementary Table S1).
One of the hallmarks of early onset CI deficiency consists
of premature death at an age below 10 years in most cases
(Koene et al., 2012). We therefore investigated adult survival,
in addition to the eclosion rates. All Drosophila models had a
severely reduced lifespan, as illustrated by plotted survival curves
(Figure 3) and reduced median survival scores (Supplementary
Table S1), the time point (day) at which 50% of adults have
died. We distinguished two groups according to severity of
survival defects: (1) CI models with a significant and modest
lifespan impairment. S4/da/25◦C and S7/da/25◦C had a median
survival of 21 and 42 days, respectively, while their control
KK/da/25◦C had a median survival of 87 days and (2) CI
models with a severe lifespan defect. This group encompassed
the S4/actin/25◦C, S7/actin/25◦C, S4/actin/28◦C, and S4/da/28◦C
models, with median survival scores of 4, 4, 3, and 2.5 days
(Figure 3 and Supplementary Table S1). Thus, like patients
with mitochondrial disorders, Drosophila models with complex
I deficiencies show dramatically shortened life expectancy.
DISCUSSION
Animals are used as models to understand aspects of human
physiology and disease pathology that cannot be addressed in
patients. In the case of pharmacological development, animal
models of diseases play a central role in evaluating the
toxicology and efficiency of novel therapeutics. In this study,
we generated and described an array of phenotypes for CI
deficiencies using Drosophila as a model and aimed to identify
conditions that could be suitable for future compound testing.
Except S7/actin/28◦C and S7/da/28◦C, all models presented a
significant KD of the genes targeted (Supplementary Figures
S1, S2) and CI deficiency (Figure 1), validating them as models
for mitochondrial CI deficiencies. In addition, the various
models showed different ranges of eclosion rate (Figure 2) and
survival defects (Figure 3) that could be classified according
to the degree of severity. Since S7/actin/28◦C and S7/da/28◦C
did not present a significant reduction of S7 mRNA level
(Supplementary Figure S1) and the OxPhos enzymatic activity
could not be reliably measured due to limited viability and
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FIGURE 3 | Consequences of CI subunits knockdown on Drosophila lifespan. Survival curves of ubiquitous (actin or da) CI subunits KD flies and their corresponding
controls. All the models, independently from the drivers and temperatures, presented a significantly shorter lifespan as compared to their respective controls
(Kaplan–Meier curves, log-rank Mantel–Cox test, statistical significances: ∗∗∗∗P < 0.0001). The median survival numerical values are reported in Supplementary
Table S1 (S4/actin/28◦C graph adapted with permission from Foriel et al., 2018).
biological material, these specific conditions are not suited to
qualify for S7 deficiency.
Although we focused on a single RNAi line per gene, we have
validated the targeted complex I KD, both at the mRNA (qPCR)
and the functional level (enzymatic activity). The specificity
of our KD phenotypes is supported by (i) the absence of
any predicted sequence-related off-target effect of the utilized
RNAi constructs/lines (see section “Materials and Methods”),
(ii) the exclusion of reported integration site-related off-targets
for the KK lines (S4 and S7) (Green et al., 2014; Vissers
et al., 2016) (methods, line 90), and (iii) the finding that the
observed phenotypes are highly consistent with each other and
in accordance with the phenotypes previously described for other
CI deficiencies (Cho et al., 2012; Burman et al., 2014; Hedge et al.,
2014; Wang et al., 2016). While also the combination of these
arguments cannot exclude the occurrence of a minor, undetected
off-target effect, they make it extremely unlikely that such off-
targets rather than the KD of the CI subunits would account
for any of the described phenotypes. It would nonetheless be
beneficial to confirm a readout of choice before its usage in a
drug screen, e.g., with an independent RNAi line or by a genetic
rescue experiment.
It would be also interesting to further characterize these
models, e.g., by measuring oxygen consumption, ATP
production, and mitochondrial morphology, to obtain more
insights into the consequences of the respective genetic and
resulting CI deficiencies.
Comparison of the Models
As expected from the temperature sensitivity of the UAS-Gal4
system, the models raised at 28◦C presented with stronger
phenotypes than the models raised at 25◦C, the only exception
being S7/actin/28◦C and S7/da/28◦C. Actin and daughterless
are ubiquitously expressed genes that are subject to dynamic
expression changes during the development (according to
Flybase data) oscillating between very high and extremely high
expression for actin and moderate to very high for daughterless.
The actin-Gal4-induced KD models were therefore expected to be
more severe, which was the case when looking at adult survival.
However, eclosion rates were more affected in da-Gal4-induced
models, which suggest that at developmental stages, this driver
has a strong component, at least in tissues requiring efficient CI
activity. This conclusion is supported by the qPCR data for S4
and S7, either of which at a given temperature shows stronger
KD at larval stage upon induction with da-Gal4 and at adult stage
with actin-Gal4. The adult survival, at least considering S4 for
which all conditions could be assessed, also grossly correlated
with this notion and with adult KD efficiency (Actin-Gal4/28◦C
being to the most stringent and da-Gal4/25◦C being the most
permissive condition).
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Intriguingly, we observed a consistent increase of CIII activity
in all the models measured. Patients with CI deficiency can
show either isolated CI deficiency or multiple OxPhos complex
deficiencies, the latter of which may include reduced CIII activity
(Budde et al., 2000; Ulgade et al., 2004). Significantly increased
CIII activity has not been reported in our clinic. Although we
cannot exclude that the observation of a significant CIII activity
increase is favored in Drosophila versus humans by less variation
due to the isogenic genetic background, our observation may also
reflect an organism-specific mechanism of the OxPhos system
or its converging pathways. Further experiments such as oxygen
consumption measurements to further understanding potentially
diverging mechanisms, and validation of any identified drug in
other systems is indispensable. In this study, we focus on CI,
and despite quantitative differences in eclosion rate and enzyme
activity, CI deficiency was efficiently induced.
Utility of the Models for Drug Screening:
Quantity Versus Quality
The use of different Gal4 lines and variation of culture
temperatures allowed us to create a panel of models with
varying severity. This, to some degree, mirrors the broad range
of severity seen in patients with defects in NDUFS4, S7, and
V1, and in mitochondrial disorders in general. This panel of
models could allow the evaluation of drugs on phenotypes of
different strength. Which one(s) to select for drug screening is
an important question and can be expected to represent a trade-
off between throughput and sensitivity. Screening for rescue
of severe phenotypes such as developmental lethality/eclosion
defects can be performed, at least with an appropriate setup, in
high throughput as demonstrated by Chang et al. (2008), for the
Drosophila model of Fragile X syndrome, but obtaining rescue
may be challenging and require highly effective drugs.
Phenotypes belonging to both ends of the spectrum have
been identified by this study. Very severe phenotypes with fully
penetrant lethality in early developmental stages would allow
quantitative screening for survivors upon drugs treatment, e.g.,
in V1/actin/25◦C. Milder phenotypes on the other hand might be
more sensitive and therefore easier to rescue but are probably less
convenient in terms of time and feasibility for the screening of
compound libraries. The reduced lifespan determined for S4 or
S7 upon induction with actin at 25◦C, S4/actin/28◦C as well as S4
or S7/da/25◦C appear to represent such conditions. Ideally, one
would go for both approaches, if possible.
Alternative Approaches
Taking advantage of the UAS-Gal4 system, the presented
phenotypes could be modulated further, e.g., by further
increasing or decreasing the temperature, by using driver lines
containing a copy of UAS-Dicer-2, or by using tissue-specific
instead of ubiquitous Gal4 lines. A principle alternative to
our approach lies in the generation of stable genetic mutants.
With the expansion of CRISPR/Cas9 gene editing technologies,
the possibilities to target each gene of interest have grown,
opening new perspectives. A CRISPR/Cas9 mutant of the
phosphomannomutase 2 (a disorder of glycosylation) presenting
lethality in larval stages has, for example, been used to perform
high throughput screening of compounds in 96 well plates3. Once
a mutant (point mutation, null mutant) with a suitable phenotype
is identified, this surely represents a valuable and powerful tool,
which may even have less variability in phenotype. However,
the challenge lies in obtaining a mutant with such a suitable
phenotype, since that system does not allow any fine-tuning and
lacks flexibility for phenotype adjustments.
Ultimately, fly models could potentially be used instead of cell-
based screening, or be utilized in parallel to cellular platforms, in
order to avoid discarding potential lead compounds that fail to
arise from in vitro studies, e.g., because they rely on a systemic
mechanism. In summary, this study and catalog of phenotypes
presented here offer relevant tools and starting points that can be
exploited to dissect the pathomechanism of CI deficiencies and
for the development of pharmaceutics through high-throughput
and/or sensitive approaches.
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FIGURE S1 | Validation of the CI subunit knockdown by qRT-PCR in larvae.
FIGURE S2 | Validation of the CI subunit knockdown by qRT-PCR in adults flies.
Transcript level of the different targeted subunits of complex I presented as
percentage of their respective isogenic background controls (mean ± SEM,
unpaired Student’s t-test, statistical significances: ns, non-significant; ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001). The numerical values are reported in Supplementary
Table S1 (qRT-PCR graph for adult flies S4/actin/28◦C reproduced/adapted with
permission from Foriel et al., 2018).
TABLE S1 | Numerical values for each phenotype quantified in the different
models: qRT-PCR in larvae, qRT-PCR in adults, OxPhos measurement, eclosion
rate, survival (median survival).
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